irinotecan has been researched along with Enterocolitis, Neutropenic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gou, R; Horikawa, N; Inayama, Y; Ito, K; Kosaka, K; Nakatani, E; Tani, H; Tsuji, M; Umemiya, M; Yoshida, T; Yu, S | 1 |
| Akaza, H; Ando, S; Kawai, K; Shimazui, T; Takaoka, E | 1 |
2 other study(ies) available for irinotecan and Enterocolitis, Neutropenic
| Article | Year |
|---|---|
Risk Factors for Septic Shock After Irinotecan-Containing Chemotherapy: An Exploratory Case-Control Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Enterocolitis, Neutropenic; Female; Genital Neoplasms, Female; Genotype; Glucuronosyltransferase; Humans; Irinotecan; Retrospective Studies; Risk Factors; Shock, Septic | 2022 |
Neutropenic colitis during standard dose combination chemotherapy with nedaplatin and irinotecan for testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chorionic Gonadotropin; Drug Administration Schedule; Enterocolitis, Neutropenic; gamma-Globulins; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Radiography, Abdominal; Testicular Neoplasms; Tomography, X-Ray Computed | 2006 |